When apelin-13 was injected intracerebroventricularly, it inhibited the activation of microglia and astrocytes and reduced the expression of IL-1β and TNF-α in a streptozotocin-induced rat model of AD [64]. The gene discussed is APLN; the disease is Alzheimer disease.